The purpose of the call for tenders is to conclude agreements with:
pharmaceutical companies within the meaning of Section 130a (8) of the Social Security Code
(SGB) Book Five (V) ('the rebate agreements' or 'rebate agreements')
a term of 24 calendar months at prescription
medicinal products and medicinal products subject to pharmacy requirements which are not
prescription only. Pursuant to § 130a (8) sentence 1 SGB V, the
Invitation to tender only to pharmaceutical companies or
Bidding consortia of pharmaceutical companies within the meaning of Section 4 (18) of the German Medicines Act (AMG). It is already made clear that for the
Lots 001 to 068 Framework contracts with three tenderers, for lots 069 to 104
framework contracts with two tenderers and for which Lots 105 to 132 may be concluded with one tenderer. In this case, a consortium is considered to be one bidder. Further details can be found in the tender documents.
Active Ingredient: Abiraterone, Prescription Type: Prescription, Dosage Form: FTA, ATC Code: L02BX03For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Active Ingredient: Buprenorphine 4 T, Prescription Type: Prescription, Dosage Form: PFT, ATC Code: N02AE01For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Active Ingredient: Tolterodine, Prescription Type: Prescription, Dosage Form: ICP Resisted, ATC Code: G04BD07For Lots 069 to 104, framework contracts will be concluded with 2 economic operators.
closed.
If, for the lots in the 2-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective
second-placed bid in respect of this lot from the ranking and the
The contract is ultimately awarded in the 1-partner model.
Active ingredient: triacylglycerol lipase, supplement see point II.2.14For Lots 069 to 104, framework contracts will be concluded with 2 economic operators.
closed.
If, for the lots in the 2-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective
second-placed bid in respect of this lot from the ranking and the
The contract is ultimately awarded in the 1-partner model.
Active Ingredient: Trimipramine, Prescription Type: Prescription, Dosage Form: LOE, LSE, TEI, ATC Code: N06AA06For Lots 069 to 104, framework contracts will be concluded with 2 economic operators.
closed.
If, for the lots in the 2-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective
second-placed bid in respect of this lot from the ranking and the
The contract is ultimately awarded in the 1-partner model.
Active Ingredient: Trospium chloride, Prescription type: Prescription, Dosage form FTA, TAB, UTA, ATC Code: G04BD09For Lots 069 to 104, framework contracts will be concluded with 2 economic operators.
closed.
If, for the lots in the 2-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective
second-placed bid in respect of this lot from the ranking and the
The contract is ultimately awarded in the 1-partner model.
Active Ingredient: Xipamide, Prescription Type: Prescription, Dosage Form: TAB, ATC Code: C03BA10For Lots 069 to 104, framework contracts will be concluded with 2 economic operators.
closed.
If, for the lots in the 2-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective
second-placed bid in respect of this lot from the ranking and the
The contract is ultimately awarded in the 1-partner model.
Active Ingredient: Amitriptyline, Prescription Type: Prescription, Dosage Form: FTA, TAB, UTA, ATC Code: N06AA09For Lots 105 to 132, framework contracts are concluded with an economic operator.
Active Ingredient: Aripiprazole, Prescription Type: Prescription, Dosage Form: LSE, ATC Code: N05AX12For Lots 105 to 132, framework contracts are concluded with an economic operator.
Active Ingredient: Betahistine dihydrochloride, Prescription type: Prescription, Dosage form: TAB, ATC code: N07CA01For Lots 105 to 132, framework contracts are concluded with an economic operator.
Active Ingredient: Budesonide, Prescription Type: Prescription, Dosage Form: DOS, ATC Code: R03BA02For Lots 105 to 132, framework contracts are concluded with an economic operator.
Active Ingredient: Budesonide, Prescription Type: Prescription, Dosage Form: IHP, ATC Code: R03BA02For Lots 105 to 132, framework contracts are concluded with an economic operator.
Active Ingredient: Buprenorphine 7 T, Prescription Type: Prescription, Dosage Form: PFT, ATC Code: N02AE01For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Active Ingredient: Budesonide, Prescription Type: Prescription, Dosage Form: NAS, SUS, ATC Code: R01AD05For Lots 105 to 132, framework contracts are concluded with an economic operator.
Active Ingredient: Buprenorphine, Prescription Type: Prescription, Dosage Form: SUT, ATC Code: N07BC01For Lots 105 to 132, framework contracts are concluded with an economic operator.
Active Ingredient: Buprenorphine 3 T, Prescription Type: Prescription, Dosage Form: PFT, ATC Code: N02AE01For Lots 105 to 132, framework contracts are concluded with an economic operator.
Active Ingredient: Cabergoline, Prescription Type: Prescription, Dosage Form: TAB, ATC Code: G02CB03For Lots 105 to 132, framework contracts are concluded with an economic operator.
Active Ingredient: Cetirizine, Prescription Type: Pharmacy Only, Dosage Form: LSE, SIR, ATC Code: R06AE07For Lots 105 to 132, framework contracts are concluded with an economic operator.
Active Ingredient: Cyproterone, Prescription Type: Prescription, Dosage Form: TAB, ATC Code: G03HA01For Lots 105 to 132, framework contracts are concluded with an economic operator.
Active Ingredient: Dexamethasone, Prescription Type: Prescription, Dosage Form: AMP, ATC Code: H02AB02For Lots 105 to 132, framework contracts are concluded with an economic operator.
Active substance: Dexamethasone, Prescription type: Prescription, Dosage form: ILO, ATC code: H02AB02For Lots 105 to 132, framework contracts are concluded with an economic operator.
Active Ingredient: Ebastin, Prescription Type: Prescription, Dosage Form: FTA, ATC Code: R06AX22For Lots 105 to 132, framework contracts are concluded with an economic operator.
Active ingredient: fenofibrate, supplement see point II.2.14For Lots 105 to 132, framework contracts are concluded with an economic operator.
Active Ingredient: Capecitabine, Prescription Type: Prescription, Dosage Form: FTA, ATC Code: L01BC06For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Active Ingredient: Fenofibrate, Prescription Type: Prescription, Dosage Form: REK, ATC Code: C10AB05For Lots 105 to 132, framework contracts are concluded with an economic operator.
Active Ingredient: Granisetron, Prescription Type: Prescription, Dosage Form: IFK, ATC Code: A04AA02For Lots 105 to 132, framework contracts are concluded with an economic operator.
Active Ingredient: Granisetron, Prescription Type: Prescription, Dosage Form: ILO, ATC Code: A04AA02For Lots 105 to 132, framework contracts are concluded with an economic operator.
Active Ingredient: Hydromorphone, Prescription Type: Prescription, Dosage Form: RET, ICP Retaded (Applic. 1xdaily), ATC Code: N02AA03For Lots 105 to 132, framework contracts are concluded with an economic operator.
Active Ingredient: Norethisterone and Estradiol, Prescription Type: Prescription, Dosage Form: FTA, TAB, ATC Code: G03FA01For Lots 105 to 132, framework contracts are concluded with an economic operator.
Active Ingredient: Octreotide, Prescription Type: Prescription, Dosage Form: PLS, ATC Code: H01CB02For Lots 105 to 132, framework contracts are concluded with an economic operator.
Active Ingredient: Ondansetron, Prescription Type: Prescription, Dosage Form: ILO, ATC Code: A04AA01For Lots 105 to 132, framework contracts are concluded with an economic operator.
Active Ingredient: Paricalcitol, Prescription Type: Prescription, Dosage Form: ILO, ATC Code: H05BX02For Lots 105 to 132, framework contracts are concluded with an economic operator.
Active Ingredient: Pipamperon, Prescription Type: Prescription, Dosage Form LSE, ATC Code: N05AD05For Lots 105 to 132, framework contracts are concluded with an economic operator.
Active ingredient piroxicam, Prescription type: Prescription, Dosage form: HKP, TAB, ATC code: M01AC01For Lots 105 to 132, framework contracts are concluded with an economic operator.
Active Ingredient: Celecoxib, Prescription Type: Prescription, Dosage Form: ICP, ATC Code: M01AH01For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Active Ingredient: Tolterodine, Prescription Type: Prescription, Dosage Form FTA, ATC Code: G04BD07For Lots 105 to 132, framework contracts are concluded with an economic operator.
Active ingredient: tolvaptan, supplement see point II.2.14For Lots 105 to 132, framework contracts are concluded with an economic operator.
Active substance: Tolvaptan - For the treatment of hyponatremia as a secondary consequence of the syndrome of inadequate secretion of antidiuretic hormone (SIADH), see point II.2.14 for supplementFor Lots 105 to 132, framework contracts are concluded with an economic operator.
Active Ingredient: Deferasirox, Prescription Type: Prescription, Dosage Form: FTA, ATC Code: V03AC03For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Active Ingredient: Dexamethasone, Prescription Type: Prescription, Dosage Form: TAB, ATC Code: H02AB02For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Wirkstoff: Donepezil, Verschreibungsart: verschreibungspflichtig, Darreichungsform: FTA, SMF, SMT, ATC-Code: N06DA02For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Active Ingredient: Dorzolamide, Prescription Type: Prescription, Dosage Form: ATR - 20 mg, ATC Code: S01EC03For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Active Ingredient: Doxazosin, Prescription Type: Prescription, Dosage Form: TAB, ATC Code: C02CA04For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Active Ingredient: Doxepin, Prescription Type: Prescription, Dosage Form: FTA, HKP, TAB, UTA, ATC Code: N06AA12For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Active ingredient: alfuzosin, Prescription type: prescription, Dosage form: RET, ATC code: G04CA01For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Active Ingredient: Duloxetine, Prescription Type: Prescription, Dosage Form: HKM, ATC Code: N06AX21For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Active Ingredient: Enalapril and Lercanidipine, Prescription Type: Prescription, Dosage Form: FTA, ATC Code: C09BB02For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Active Ingredient: Esomeprazole, Prescription Type: Prescription, Dosage Form: HKM, TMR, ATC Code: A02BC05For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Active Ingredient: Finasteride, Prescription Type: Prescription, Dosage Form: FTA, ATC Code: G04CB01For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Active Ingredient: Flecainide, Prescription Type: Prescription, Dosage Form: TAB, ATC Code: C01BC04For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Active Ingredient: Fluticasone-17 Propionate and Salmeterol, Prescription Type: Prescription, Dosage Form: DOS, ATC Code: R03AK06For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Active Ingredient: Fluticasone-17 Propionate and Salmeterol, Prescription Type: Prescription, Dosage Form: IHP, ATC Code: R03AK06For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Active Ingredient: Galantamine, Prescription Type: Prescription, Dosage Form: REK, ATC Code: N06DA04For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Active Ingredient: Hydromorphone, Prescription Type: Prescription, Dosage Form: RET, ICP Remedied (Applic. 2xdaily), ATC Code: N02AA03For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Active Ingredient: Irbesartan and Hydrochlorothiazide, Prescription Type: Prescription, Dosage Form: FTA, TAB, ATC Code: C09DA04For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Active Ingredient: Amiodarone, Prescription Type: Prescription, Dosage Form: TAB, ATC Code: C01BD01For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Active Ingredient: Ivermectin, Prescription Type: Prescription, Dosage Form: TAB, ATC Code: P02CF01For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Active Ingredient: Lamotrigine, Prescription Type: Prescription, Dosage Form: TAB, TSE, ATC Code: N03AX09For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Active Ingredient: Leflunomide, Prescription Type: Prescription, Dosage Form: FTA, TAB, ATC Code: L04AA13For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Active Ingredient: Letrozole, Prescription Type: Prescription, Dosage Form: FTA, ATC Code: L02BG04For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Wirkstoff: Levetiracetam, Verschreibungsart: verschreibungspflichtig, Darreichungsform: FTA, ATC-Code: N03AX14For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Active Ingredient: Levetiracetam, Prescription Type: Prescription, Dosage Form: LSE, ATC Code: N03AX14For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Active Ingredient: Levodopa and Benserazide, Prescription Type: Prescription, Dosage Form: HKP, TAB, ATC Code: N04BA02For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Active Ingredient: Lisinopril and Hydrochlorothiazide, Prescription Type: Prescription, Dosage Form: TAB, ATC Code: C09BA03For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Active Ingredient: Melperone, Prescription Type: Prescription, Dosage Form: FTA, UTA, ATC Code: N05AD03For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Active Ingredient: Melperone, Prescription Type: Prescription, Dosage Form: LSE, ATC Code: N05AD03For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Active Ingredient: Anastrozole, Prescription Type: Prescription, Dosage Form: FTA, ATC Code: L02BG03For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Wirkstoff: Olmesartan, Verschreibungsart: verschreibungspflichtig, Darreichungsform: FTA, ATC-Code: C09CA08For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Active ingredient: ondansetron, Prescription type: prescription, Dosage form: FTA, SMF, SMT, ATC Code: A04AA01For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Active Ingredient: Opipramol, Prescription Type: Prescription, Dosage Form: FTA, UTA, ATC Code: N06AA05For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Active Ingredient: Oxcarbazepine, Prescription Type: Prescription, Dosage Form: FTA, ATC Code: N03AF02For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Active Ingredient: Pramipexole, Prescription Type: Prescription, Dosage Form: RET, ATC Code: N04BC05For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Active Ingredient: Pramipexole, Prescription Type: Prescription, Dosage Form: TAB, ATC Code: N04BC05For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Active Ingredient: Quetiapine, Prescription Type: Prescription, Dosage Form: FTA, ATC Code: N05AH04For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Active Ingredient: Rasagiline, Prescription Type: Prescription, Dosage Form: TAB, ATC Code: N04BD02For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Active Ingredient: Risedronic Acid, Prescription Type: Prescription, Dosage Form: FTA, ATC Code: M05BA07For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Active Ingredient: Rizatriptan, Prescription Type: Prescription, Dosage Form: SMT, ATC Code: N02CC04For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Active Ingredient: Aripiprazole, Prescription Type: Prescription, Dosage Form: TAB, SMT, ATC Code: N05AX12For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Wirkstoff: Roflumilast, Verschreibungsart: verschreibungspflichtig, Darreichungsform: FTA, ATC-Code: R03DX07For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Active Ingredient: Ropinirol, Prescription Type: Prescription, Dosage Form: FTA, ATC Code: N04BC04For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Active Ingredient: Ropinirol, Prescription Type: Prescription, Dosage Form: RET, ATC Code: N04BC04For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Active Ingredient: Sertraline, Prescription Type: Prescription, Dosage Form: FTA, ATC Code: N06AB06For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Active Ingredient: Sevelamer carbonate, Prescription type: Prescription, Dosage form FTA: ATC code: V03AE02For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Active Ingredient: Sildenafil, Prescription Type: Prescription, Dosage Form: FTA, ATC Code: G04BE03For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Wirkstoff: Telmisartan, Verschreibungsart: verschreibungspflichtig, Darreichungsform: FTA, TAB, ATC-Code: C09CA07For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Active Ingredient: Telmisartan and Hydrochlorothiazide, Prescription Type: Prescription, Dosage Form: FTA, TAB, ATC Code: C09DA07For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Active Ingredient: Temozolomide, Prescription Type: Prescription, Dosage Form: ICP, ATC Code: L01AX03For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Active Ingredient: Terbinafine, Prescription Type: Prescription, Dosage Form: TAB, ATC Code: D01BA02For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Active Ingredient: Atenolol, Prescription Type: Prescription, Dosage Form: FTA, TAB, ATC Code: C07AB03For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Active Ingredient: Timolol, Prescription Type: Prescription, Dosage Form: ATR, ATC Code: S01ED01For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Active Ingredient: Tolperisone, Prescription Type: Prescription, Dosage Form: FTA, ATC Code: M03BX04For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Active Ingredient: Trimipramine, Prescription Type: Prescription, Dosage Form: FTA, TAB, ATC Code: N06AA06For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Wirkstoff: Valsartan, Verschreibungsart: verschreibungspflichtig, Darreichungsform: FTA, ATC-Code: C09CA03For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Active Ingredient: Valsartan and Hydrochlorothiazide, Prescription Type: Prescription, Dosage Form: FTA, ATC Code: C09DA03For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Active Ingredient: Ziprasidone Prescription Type: Prescription, Dosage Form: ICP, ATC Code: N05AE04For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Active Ingredient: Zoledronic Acid, Prescription Type: Prescription, Dosage Form: IFK, ATC Code: M05BA08For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Active Ingredient: Zolpidem, Prescription Type: Prescription, Dosage Form: FTA, ATC Code: N05CF02For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Active Ingredient: Zopiclone, Prescription Type: Prescription, Dosage Form: FTA, TAB, ATC Code: N05CF01For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Active ingredient: Acarbose, Prescription type: prescription, Dosage form: TAB, ATC Code: A10BF01For Lots 069 to 104, framework contracts will be concluded with 2 economic operators.
closed.
If, for the lots in the 2-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective
second-placed bid in respect of this lot from the ranking and the
The contract is ultimately awarded in the 1-partner model.
Active Ingredient: Azathioprine, Prescription Type: Prescription, Dosage Form: FTA, TAB, ATC Code: L04AX01For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Active Ingredient: Atomoxetine, Prescription Type: Prescription, Dosage Form: ICP, ATC Code: N06BA09For Lots 069 to 104, framework contracts will be concluded with 2 economic operators.
closed.
If, for the lots in the 2-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective
second-placed bid in respect of this lot from the ranking and the
The contract is ultimately awarded in the 1-partner model.
Active ingredient: Betahistine dimesilate, Prescription type: Prescription, Dosage form: TAB, ATC code: N07CA01For Lots 069 to 104, framework contracts will be concluded with 2 economic operators.
closed.
If, for the lots in the 2-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective
second-placed bid in respect of this lot from the ranking and the
The contract is ultimately awarded in the 1-partner model.
Active Ingredient: Bromazepam, Prescription Type: Prescription, Dosage Form: TAB, ATC Code: N05BA08For Lots 069 to 104, framework contracts will be concluded with 2 economic operators.
closed.
If, for the lots in the 2-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective
second-placed bid in respect of this lot from the ranking and the
The contract is ultimately awarded in the 1-partner model.
Active Ingredient: Cinnarizine and Dimenhydrinate, Prescription Type: Prescription, Dosage Form: TAB, ATC Code: N07CA52For Lots 069 to 104, framework contracts will be concluded with 2 economic operators.
closed.
If, for the lots in the 2-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective
second-placed bid in respect of this lot from the ranking and the
The contract is ultimately awarded in the 1-partner model.
Active Ingredient: Domperidone, Prescription Type: Prescription, Dosage Form: FTA, TAB, ATC Code: A03FA03For Lots 069 to 104, framework contracts will be concluded with 2 economic operators.
closed.
If, for the lots in the 2-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective
second-placed bid in respect of this lot from the ranking and the
The contract is ultimately awarded in the 1-partner model.
Active Ingredient: Doxazosin, Prescription Type: Prescription, DOSAGE FORM RET, ATC Code: C02CA04For Lots 069 to 104, framework contracts will be concluded with 2 economic operators.
closed.
If, for the lots in the 2-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective
second-placed bid in respect of this lot from the ranking and the
The contract is ultimately awarded in the 1-partner model.
Active Ingredient: Fampridine, Prescription Type: Prescription, Dosage Form: RET, ATC Code: N07XX07For Lots 069 to 104, framework contracts will be concluded with 2 economic operators.
closed.
If, for the lots in the 2-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective
second-placed bid in respect of this lot from the ranking and the
The contract is ultimately awarded in the 1-partner model.
Active ingredient: Fusidic acid and betamethasone, Prescription type: Prescription, Dosage form: CRE, ATC Code: D07CC01For Lots 069 to 104, framework contracts will be concluded with 2 economic operators.
closed.
If, for the lots in the 2-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective
second-placed bid in respect of this lot from the ranking and the
The contract is ultimately awarded in the 1-partner model.
Active Ingredient: Ginkgo Leaf Dry Extract, Prescription Type: Pharmacy Only, Dosage Form: FTA, ATC Code: N06DX02For Lots 069 to 104, framework contracts will be concluded with 2 economic operators.
closed.
If, for the lots in the 2-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective
second-placed bid in respect of this lot from the ranking and the
The contract is ultimately awarded in the 1-partner model.
Wirkstoff: Granisetron, Verschreibungsart: verschreibungspflichtig, Darreichungsform: FTA, ATC-Code: A04AA02For Lots 069 to 104, framework contracts will be concluded with 2 economic operators.
closed.
If, for the lots in the 2-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective
second-placed bid in respect of this lot from the ranking and the
The contract is ultimately awarded in the 1-partner model.
Active Ingredient: Brimonidine, Prescription Type: Prescription, Dosage Form ATR, ATC Code: S01EA05For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Active Ingredient: Isotretinoin, Prescription Type: Prescription, Dosage Form KAP, WKA, ATC Code: D10BA01For Lots 069 to 104, framework contracts will be concluded with 2 economic operators.
closed.
If, for the lots in the 2-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective
second-placed bid in respect of this lot from the ranking and the
The contract is ultimately awarded in the 1-partner model.
Active Ingredient: Lansoprazole, Prescription Type: Prescription, Dosage Form: HKM, ATC Code: A02BC03For Lots 069 to 104, framework contracts will be concluded with 2 economic operators.
closed.
If, for the lots in the 2-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective
second-placed bid in respect of this lot from the ranking and the
The contract is ultimately awarded in the 1-partner model.
Active Ingredient: Lorazepam, Prescription Type: Prescription, Dosage Form: SMT, TAB, Oral Lyophilisate, ATC Code: N05BA06For Lots 069 to 104, framework contracts will be concluded with 2 economic operators.
closed.
If, for the lots in the 2-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective
second-placed bid in respect of this lot from the ranking and the
The contract is ultimately awarded in the 1-partner model.
Active Ingredient: Methylphenidate, Prescription Type: Prescription, Dosage Form: RET, ATC Code: N06BA04For Lots 069 to 104, framework contracts will be concluded with 2 economic operators.
closed.
If, for the lots in the 2-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective
second-placed bid in respect of this lot from the ranking and the
The contract is ultimately awarded in the 1-partner model.
Active Ingredient: Methylphenidate, Prescription Type: Prescription, Dosage Form: TAB, ATC Code: N06BA04For Lots 069 to 104, framework contracts will be concluded with 2 economic operators.
closed.
If, for the lots in the 2-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective
second-placed bid in respect of this lot from the ranking and the
The contract is ultimately awarded in the 1-partner model.
Active ingredient: metoprolol tartrate and hydrochlorothiazide, Prescription type: prescription, Dosage form: TAB, ATC Code: C07BB02For Lots 069 to 104, framework contracts will be concluded with 2 economic operators.
closed.
If, for the lots in the 2-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective
second-placed bid in respect of this lot from the ranking and the
The contract is ultimately awarded in the 1-partner model.
Active Ingredient: Molsidomine, Prescription Type: Prescription, Dosage Form: RET, ATC Code: C01DX12For Lots 069 to 104, framework contracts will be concluded with 2 economic operators.
closed.
If, for the lots in the 2-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective
second-placed bid in respect of this lot from the ranking and the
The contract is ultimately awarded in the 1-partner model.
Wirkstoff: Naproxen, Verschreibungsart: verschreibungspflichtig, Darreichungsform: FTA, TAB, TMR, ATC-Code: M01AE02For Lots 069 to 104, framework contracts will be concluded with 2 economic operators.
closed.
If, for the lots in the 2-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective
second-placed bid in respect of this lot from the ranking and the
The contract is ultimately awarded in the 1-partner model.
Active Ingredient: Naratriptan, Prescription Type: Prescription, Dosage Form: FTA, ATC Code: N02CC02For Lots 069 to 104, framework contracts will be concluded with 2 economic operators.
closed.
If, for the lots in the 2-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective
second-placed bid in respect of this lot from the ranking and the
The contract is ultimately awarded in the 1-partner model.
Active Ingredient: Nitrendipine, Prescription Type: Prescription, Dosage Form: FTA, TAB, ATC Code: C08CA08For Lots 069 to 104, framework contracts will be concluded with 2 economic operators.
closed.
If, for the lots in the 2-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective
second-placed bid in respect of this lot from the ranking and the
The contract is ultimately awarded in the 1-partner model.
Active Ingredient: Budesonide and Formoterol Hemifumarate-1 Water, Prescription Type: Prescription, Dosage Form: IHP, ATC Code: R03AK07For Lots 001 to 068, framework contracts will be concluded with 3 economic operators.
closed.
If, for the lots in the 3-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective second and second
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 1-partner model.
If, for the lots in the 3-partner model, the difference in the savings
between the potential second and third place winners
of a lot be greater than 40%, then the respective
third-placed bid for this lot from the scoring and the winning bid
ultimately takes place in the 2-partner model.
Active Ingredient: Olmesartan and Hydrochlorothiazide, Prescription Type: Prescription, Dosage Form: FTA, ATC Code: C09DA08For Lots 069 to 104, framework contracts will be concluded with 2 economic operators.
closed.
If, for the lots in the 2-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective
second-placed bid in respect of this lot from the ranking and the
The contract is ultimately awarded in the 1-partner model.
Active Ingredient: Oxazepam, Prescription Type: Prescription, Dosage Form: TAB, ATC Code: N05BA04For Lots 069 to 104, framework contracts will be concluded with 2 economic operators.
closed.
If, for the lots in the 2-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective
second-placed bid in respect of this lot from the ranking and the
The contract is ultimately awarded in the 1-partner model.
Active Ingredient: Oxybutynin, Prescription Type: Prescription, Dosage Form: TAB, ATC Code: G04BD04For Lots 069 to 104, framework contracts will be concluded with 2 economic operators.
closed.
If, for the lots in the 2-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective
second-placed bid in respect of this lot from the ranking and the
The contract is ultimately awarded in the 1-partner model.
Active Ingredient: Pamidronic Acid, Prescription Type: Prescription, Dosage Form: IFK, ATC Code: M05BA03For Lots 069 to 104, framework contracts will be concluded with 2 economic operators.
closed.
If, for the lots in the 2-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective
second-placed bid in respect of this lot from the ranking and the
The contract is ultimately awarded in the 1-partner model.
Active Ingredient: Pipamperon, Prescription Type: Prescription, Dosage Form: TAB, ATC Code: N05AD05For Lots 069 to 104, framework contracts will be concluded with 2 economic operators.
closed.
If, for the lots in the 2-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective
second-placed bid in respect of this lot from the ranking and the
The contract is ultimately awarded in the 1-partner model.
Wirkstoff: Propranolol, Verschreibungsart: verschreibungspflichtig, Darreichungsform: FTA, LTA, TAB, ATC-Code: C07AA05For Lots 069 to 104, framework contracts will be concluded with 2 economic operators.
closed.
If, for the lots in the 2-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective
second-placed bid in respect of this lot from the ranking and the
The contract is ultimately awarded in the 1-partner model.
Active Ingredient: Repaglinide, Prescription Type: Prescription, Dosage Form: TAB, ATC Code: A10BX02For Lots 069 to 104, framework contracts will be concluded with 2 economic operators.
closed.
If, for the lots in the 2-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective
second-placed bid in respect of this lot from the ranking and the
The contract is ultimately awarded in the 1-partner model.
Active Ingredient: Rizatriptan, Prescription Type: Prescription, Dosage Form: TAB, ATC Code: N02CC04For Lots 069 to 104, framework contracts will be concluded with 2 economic operators.
closed.
If, for the lots in the 2-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective
second-placed bid in respect of this lot from the ranking and the
The contract is ultimately awarded in the 1-partner model.
Active Ingredient: Tilidine Hydrochloride and Naloxone Hydrochloride, Prescription Type: Prescription, Dosage Form: LOE, LSE, TEI, ATC Code: N02AX51For Lots 069 to 104, framework contracts will be concluded with 2 economic operators.
closed.
If, for the lots in the 2-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective
second-placed bid in respect of this lot from the ranking and the
The contract is ultimately awarded in the 1-partner model.
Active Ingredient Tilidine Hydrochloride and Naloxone Hydrochloride, Prescription Type: Prescription, Dosage Form: RET, ATC Code: N02AX51For Lots 069 to 104, framework contracts will be concluded with 2 economic operators.
closed.
If, for the lots in the 2-partner model, the difference in the savings
between the potential first and second place winners
of a lot be greater than 40%, then the respective
second-placed bid in respect of this lot from the ranking and the
The contract is ultimately awarded in the 1-partner model.